Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
- 1Department of Oral and Maxillofacial Surgery, The Chaim Sheba Medical Center, Tel Hashomer, Israel
- 2Head and Neck Cancer Unit, The Chaim Sheba Medical Center, Institute of Oncology, Tel Hashomer, Israel
- 3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
- 4Department of Otolaryngology—Head and Neck Surgery, The Chaim Sheba Medical Center, Tel Hashomer, Israel
- 5The Chaim Sheba Medical Center, Institute of Pathology, Tel Hashomer, Israel
- 6Department of Oral Pathology, Oral Medicine and Maxillofacial Imaging, School of Dentistry, Tel Aviv University, Tel Aviv, Israel
Citation: Dobriyan A, Gluck I, Alon E, Barshack I, Yahalom R and Vered M (2021) Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings. Front. Oral. Health 2:653104. doi: 10.3389/froh.2021.653104
Received: 13 January 2021; Accepted: 22 March 2021;
Published: 23 April 2021; Retracted: 22 March 2022.
Edited by:
Ricardo D. Coletta, Campinas State University, BrazilReviewed by:
Tine M. Søland, University of Oslo, NorwayLuiz Alcino Gueiros, Federal University of Pernambuco, Brazil